Daksh Pharma Pvt Ltd
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Glimidac-MV1 Tablet SR is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet SR
Glimidac-MV1 Tablet SR is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimidac-MV1 Tablet SR is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glimidac-MV1 Tablet SR.
Glimidac-MV1 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glimidac-MV1 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glimidac-MV1 Tablet SR is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Glimidac-MV1 Tablet SR is a combination medication containing Glimepiride, Metformin and Voglibose. It's used for the treatment of type 2 diabetes mellitus (DM). It works by lowering blood glucose levels in adults when taken alongside proper diet and exercise. Glimepiride increases insulin release from the pancreas, metformin reduces liver glucose production and improves insulin sensitivity, and voglibose lowers postprandial (after meals) glucose levels. This combination is not indicated for the treatment of type 1 DM.
Common side effects associated with Glimidac-MV1 Tablet SR include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection. Seek immediate medical attention if any severe or unusual side effects occur.
It's important to avoid Glimidac-MV1 Tablet SR in individuals with known allergies to any of its components or excipients. Additionally, it is not recommended for patients with moderate to severe kidney disease, inflammatory bowel diseases (IBD), colonic ulcers, or underlying metabolic acidosis including diabetic ketoacidosis.
No, taking Glimidac-MV1 Tablet SR with alcohol is not recommended. This combination may lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, Glimidac-MV1 Tablet SR can potentially cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feelings of anxiety or shakiness. It's more likely to occur when missing meals, consuming alcohol, exercising excessively, or taking other antidiabetic medications concurrently.
Store this medication in its original packaging, securely sealed. Follow the storage instructions on the pack label or package. Do not discard unused medicine. Make sure it is out of reach of pets, children, and others.